Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remifentanil vs Sufentanil in Cardiac Surgery
NCT02053818Phase 4Completed
- Sponsor
- Aarhus University Hospital
- Start
- Aug 2011
- Primary completion
- Jun 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of remifentanil in ischemic heart disease (IHD), aortic stenosis (AS), sponsored by Aarhus University Hospital. Started Aug 2011; status: completed.
02
Drugs
remifentanil
03
Conditions
ischemic heart disease (IHD)aortic stenosis (AS)
Beyond the preview
Go deeper on NCT02053818.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02053818.